Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine

By Jertborn M.   Svennerholm A.-M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1459-1465

Elsevier

Access to resources Recommend Favorite

Serum antibacterial and antitoxin responses in clinical cholera caused by Vibrio cholerae O139 Bengal and evaluation of their importance in protection

By Nandy R.K.   Albert M.J.   Ghose A.C.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1137-1142

Elsevier

Access to resources Recommend Favorite

Antibodies to the truncated (short) form of `O' polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strains and such protection is mediated by inhibition of intestinal colonization of vibrios

By Nandy R.K.   Mukhopadhyay S.   Ghosh A.N.   Ghose A.C.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2844-2852

Elsevier

Access to resources Recommend Favorite

Mutants of cholera toxin as an effective and safe adjuvant for nasal influenza vaccine

By Hagiwara Y.   Komase K.   Chen Z.   Matsuo K.   Suzuki Y.   Aizawa C.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 17, Iss. 22, 1999-07 ,pp. : 2918-2926

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective role of three formulations of oral cholera vaccine

By Kalambaheti T.   Chaisri U.   Srimanote P.   Pongponratn E.   Chaicumpa W.  

Vaccine, Vol. 16, Iss. 2, 1998-01 ,pp. : 201-207

Elsevier

Access to resources Recommend Favorite